TE_30033
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | AluSc5 |
|---|---|
| TE superfamily | Alu |
| TE order | SINE |
| Gene | TPSB2 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 0.04 |
| Counts of samples | TCGA_tumor:59; TCGA_normal:6; GTEx:1720 |
| TSS | chr16(-):1233013 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_30033.1 | TPSB2 | Chimeric | Non-coding | Non-coding | chr16(-):1228794,1228814,1228900,1229063,1229191,1229456,1229566,1229737,1229891,1229951,1232491,1232705,1232956,1233014 |
| teRNA_30033.2 | TPSB2 | Chimeric | Non-coding | Non-coding | chr16(-):1228794,1228814,1228900,1229063,1229191,1229456,1229566,1229737,1229891,1229951,1232491,1232746,1232956,1233014 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
